SINOVAC BIOTECH LTD. - Common Shares (SVA)

Q1 2024 13F Holders as of 3/31/2024

Type / Class: Equity / Common Shares
Shares outstanding: 71.9M
Number of holders: 11
Total 13F shares, excl. options: 12.3M
Shares change: +12M
Total reported value, excl. options: $79.9M
Value change: +$77.8M
Number of buys: 8
Price: $6.47

Significant Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q1 2024

11 filings reported holding SVA - SINOVAC BIOTECH LTD. - Common Shares as of Q1 2024.
SINOVAC BIOTECH LTD. - Common Shares (SVA) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 12.3M shares of 71.9M outstanding shares and own 17.18% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (11.8M shares), Neumann Advisory Hong Kong Ltd (316K shares), STATE STREET CORP (161K shares), GEODE CAPITAL MANAGEMENT, LLC (27.7K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (16.4K shares), WELLS FARGO & COMPANY/MN (12.8K shares), MORGAN STANLEY (6.92K shares), JPMORGAN CHASE & CO (3K shares), UBS Group AG (2.1K shares), and GROUP ONE TRADING, L.P. (412 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.